Measuring medication

Do interviews agree with medical record and pharmacy data?

Philip (Todd) Korthuis, Steven Asch, Martha Mancewicz, Martin F. Shapiro, W. Christopher Mathews, William E. Cunningham, J. Allen Mccutchan, Allen Gifford, Martin L. Lee, Samuel A. Bozzette

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

BACKGROUND. Medication measurement is crucial in assessing quality for chronic conditions yet agreement of alternate data sources remains uncertain. OBJECTIVES. To evaluate medication agreement between interviews, medical records, and pharmacy data; to assess data source contribution to attributing medication exposure; and to describe the impact of combining data sources on models that predict medication use. RESEARCH DESIGN. Prospective cohort study. SUBJECTS. Probability sample of HIVinfected participants in the HIV Cost and Services Utilization Study.MEASURES. Medications reported in 2267 interviews, 1936 medical records, and 457 pharmacy records were compared using crude agreement, kappa, and the proportion of average positive and negative agreement. The percent of medications reported in each source alone was used to assess their relative contribution to attributing exposure status. We performed weighted logistic regression in alternate data sources. RESULTS. Kappa varied from 0.38 for nucleoside reverse transcriptase inhibitors to 0.70 for protease inhibitors, when comparing drug classes in interview versus medical record, interview versus pharmacy data, and medical record versus pharmacy data. The percentage of medications reported in medical records was greater than that reported in interviews or pharmacy data. Pharmacy data contributed little to the attribution of medication exposure. Adding medication data to interview data did not appreciably change analytic models predicting medication use.CONCLUSIONS. For specific medications, agreement between alternative data sources is fair to substantial, but is lower for key drug classes. Relying on one data source may lead to misclassification of drug exposure status, but combining data sources does not change the results of analytic models predicting appropriate medication use.

Original languageEnglish (US)
Pages (from-to)1270-1282
Number of pages13
JournalMedical Care
Volume40
Issue number12
DOIs
StatePublished - Dec 2002
Externally publishedYes

Fingerprint

Information Storage and Retrieval
Medical Records
medication
Interviews
interview
Pharmaceutical Preparations
Sampling Studies
Reverse Transcriptase Inhibitors
drug
Protease Inhibitors
Nucleosides
Cohort Studies
Logistic Models
HIV
Prospective Studies
Costs and Cost Analysis
attribution

Keywords

  • Cohort studies
  • Epidemiology
  • HIV disease/AIDS
  • Medications
  • Methodology

ASJC Scopus subject areas

  • Nursing(all)
  • Public Health, Environmental and Occupational Health
  • Health(social science)
  • Health Professions(all)

Cite this

Korthuis, P. T., Asch, S., Mancewicz, M., Shapiro, M. F., Mathews, W. C., Cunningham, W. E., ... Bozzette, S. A. (2002). Measuring medication: Do interviews agree with medical record and pharmacy data? Medical Care, 40(12), 1270-1282. https://doi.org/10.1097/00005650-200212000-00014

Measuring medication : Do interviews agree with medical record and pharmacy data? / Korthuis, Philip (Todd); Asch, Steven; Mancewicz, Martha; Shapiro, Martin F.; Mathews, W. Christopher; Cunningham, William E.; Mccutchan, J. Allen; Gifford, Allen; Lee, Martin L.; Bozzette, Samuel A.

In: Medical Care, Vol. 40, No. 12, 12.2002, p. 1270-1282.

Research output: Contribution to journalArticle

Korthuis, PT, Asch, S, Mancewicz, M, Shapiro, MF, Mathews, WC, Cunningham, WE, Mccutchan, JA, Gifford, A, Lee, ML & Bozzette, SA 2002, 'Measuring medication: Do interviews agree with medical record and pharmacy data?', Medical Care, vol. 40, no. 12, pp. 1270-1282. https://doi.org/10.1097/00005650-200212000-00014
Korthuis, Philip (Todd) ; Asch, Steven ; Mancewicz, Martha ; Shapiro, Martin F. ; Mathews, W. Christopher ; Cunningham, William E. ; Mccutchan, J. Allen ; Gifford, Allen ; Lee, Martin L. ; Bozzette, Samuel A. / Measuring medication : Do interviews agree with medical record and pharmacy data?. In: Medical Care. 2002 ; Vol. 40, No. 12. pp. 1270-1282.
@article{42ef6993e2f14a339bd0bf8cc23e19b9,
title = "Measuring medication: Do interviews agree with medical record and pharmacy data?",
abstract = "BACKGROUND. Medication measurement is crucial in assessing quality for chronic conditions yet agreement of alternate data sources remains uncertain. OBJECTIVES. To evaluate medication agreement between interviews, medical records, and pharmacy data; to assess data source contribution to attributing medication exposure; and to describe the impact of combining data sources on models that predict medication use. RESEARCH DESIGN. Prospective cohort study. SUBJECTS. Probability sample of HIVinfected participants in the HIV Cost and Services Utilization Study.MEASURES. Medications reported in 2267 interviews, 1936 medical records, and 457 pharmacy records were compared using crude agreement, kappa, and the proportion of average positive and negative agreement. The percent of medications reported in each source alone was used to assess their relative contribution to attributing exposure status. We performed weighted logistic regression in alternate data sources. RESULTS. Kappa varied from 0.38 for nucleoside reverse transcriptase inhibitors to 0.70 for protease inhibitors, when comparing drug classes in interview versus medical record, interview versus pharmacy data, and medical record versus pharmacy data. The percentage of medications reported in medical records was greater than that reported in interviews or pharmacy data. Pharmacy data contributed little to the attribution of medication exposure. Adding medication data to interview data did not appreciably change analytic models predicting medication use.CONCLUSIONS. For specific medications, agreement between alternative data sources is fair to substantial, but is lower for key drug classes. Relying on one data source may lead to misclassification of drug exposure status, but combining data sources does not change the results of analytic models predicting appropriate medication use.",
keywords = "Cohort studies, Epidemiology, HIV disease/AIDS, Medications, Methodology",
author = "Korthuis, {Philip (Todd)} and Steven Asch and Martha Mancewicz and Shapiro, {Martin F.} and Mathews, {W. Christopher} and Cunningham, {William E.} and Mccutchan, {J. Allen} and Allen Gifford and Lee, {Martin L.} and Bozzette, {Samuel A.}",
year = "2002",
month = "12",
doi = "10.1097/00005650-200212000-00014",
language = "English (US)",
volume = "40",
pages = "1270--1282",
journal = "Medical Care",
issn = "0025-7079",
publisher = "Lippincott Williams and Wilkins",
number = "12",

}

TY - JOUR

T1 - Measuring medication

T2 - Do interviews agree with medical record and pharmacy data?

AU - Korthuis, Philip (Todd)

AU - Asch, Steven

AU - Mancewicz, Martha

AU - Shapiro, Martin F.

AU - Mathews, W. Christopher

AU - Cunningham, William E.

AU - Mccutchan, J. Allen

AU - Gifford, Allen

AU - Lee, Martin L.

AU - Bozzette, Samuel A.

PY - 2002/12

Y1 - 2002/12

N2 - BACKGROUND. Medication measurement is crucial in assessing quality for chronic conditions yet agreement of alternate data sources remains uncertain. OBJECTIVES. To evaluate medication agreement between interviews, medical records, and pharmacy data; to assess data source contribution to attributing medication exposure; and to describe the impact of combining data sources on models that predict medication use. RESEARCH DESIGN. Prospective cohort study. SUBJECTS. Probability sample of HIVinfected participants in the HIV Cost and Services Utilization Study.MEASURES. Medications reported in 2267 interviews, 1936 medical records, and 457 pharmacy records were compared using crude agreement, kappa, and the proportion of average positive and negative agreement. The percent of medications reported in each source alone was used to assess their relative contribution to attributing exposure status. We performed weighted logistic regression in alternate data sources. RESULTS. Kappa varied from 0.38 for nucleoside reverse transcriptase inhibitors to 0.70 for protease inhibitors, when comparing drug classes in interview versus medical record, interview versus pharmacy data, and medical record versus pharmacy data. The percentage of medications reported in medical records was greater than that reported in interviews or pharmacy data. Pharmacy data contributed little to the attribution of medication exposure. Adding medication data to interview data did not appreciably change analytic models predicting medication use.CONCLUSIONS. For specific medications, agreement between alternative data sources is fair to substantial, but is lower for key drug classes. Relying on one data source may lead to misclassification of drug exposure status, but combining data sources does not change the results of analytic models predicting appropriate medication use.

AB - BACKGROUND. Medication measurement is crucial in assessing quality for chronic conditions yet agreement of alternate data sources remains uncertain. OBJECTIVES. To evaluate medication agreement between interviews, medical records, and pharmacy data; to assess data source contribution to attributing medication exposure; and to describe the impact of combining data sources on models that predict medication use. RESEARCH DESIGN. Prospective cohort study. SUBJECTS. Probability sample of HIVinfected participants in the HIV Cost and Services Utilization Study.MEASURES. Medications reported in 2267 interviews, 1936 medical records, and 457 pharmacy records were compared using crude agreement, kappa, and the proportion of average positive and negative agreement. The percent of medications reported in each source alone was used to assess their relative contribution to attributing exposure status. We performed weighted logistic regression in alternate data sources. RESULTS. Kappa varied from 0.38 for nucleoside reverse transcriptase inhibitors to 0.70 for protease inhibitors, when comparing drug classes in interview versus medical record, interview versus pharmacy data, and medical record versus pharmacy data. The percentage of medications reported in medical records was greater than that reported in interviews or pharmacy data. Pharmacy data contributed little to the attribution of medication exposure. Adding medication data to interview data did not appreciably change analytic models predicting medication use.CONCLUSIONS. For specific medications, agreement between alternative data sources is fair to substantial, but is lower for key drug classes. Relying on one data source may lead to misclassification of drug exposure status, but combining data sources does not change the results of analytic models predicting appropriate medication use.

KW - Cohort studies

KW - Epidemiology

KW - HIV disease/AIDS

KW - Medications

KW - Methodology

UR - http://www.scopus.com/inward/record.url?scp=11244338084&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=11244338084&partnerID=8YFLogxK

U2 - 10.1097/00005650-200212000-00014

DO - 10.1097/00005650-200212000-00014

M3 - Article

VL - 40

SP - 1270

EP - 1282

JO - Medical Care

JF - Medical Care

SN - 0025-7079

IS - 12

ER -